Grants per year
Fingerprint
Dive into the research topics where Mara Aspinall is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 3 Finished
-
RADx-UP Coordination and Data Collection Center - CDCC
Wade, N. (CoI) & Aspinall, M. (PI)
HHS: National Institutes of Health (NIH)
9/1/21 → 12/31/22
Project: Research project
-
COVID-19 Evidence Commons
Aspinall, M. (PI) & Wade, N. (CoI)
7/1/21 → 6/30/23
Project: Research project
-
COVID-19 Diagnostics Commons
Wade, N. (CoI) & Aspinall, M. (PI)
7/1/20 → 5/31/22
Project: Research project
-
A Pandemic Not Just of Infection but of Inequality: The Social Impact of COVID-19
Aspinall, M. & Ruark, L., Jan 1 2024, Accelerating Diagnostics in a Time of Crisis: The Response to COVID-19 and a Roadmap for Future Pandemics. Cambridge University Press, p. 250-262 13 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
1 Link opens in a new tab Scopus citations -
The United States Needs A Better Testing Playbook For Future Public Health Emergencies
Nuzzo, J. B., Person, A., Cameron, E., Taylor, J., King, E., Aspinall, M. & Becker, S., Jun 2024, In: Health Affairs. 43, 6, p. 768-775 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Author Correction: Supporting US public health experts (Nature Biotechnology, (2020), 38, 12, (1381-1384), 10.1038/s41587-020-00767-6)
Cosignatories, Jan 2021, In: Nature biotechnology. 39, 1, p. 115 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Executive summary: It's wrong not to test: The case for universal, frequent rapid COVID-19 testing
Rapid Tests Working Group, Mar 2021, In: EClinicalMedicine. 33, 100759.Research output: Contribution to journal › Comment/debate › peer-review
Open Access11 Link opens in a new tab Scopus citations -
Supporting US public health experts
Cosignatories, Dec 2020, In: Nature biotechnology. 38, 12, p. 1381-1384 4 p.Research output: Contribution to journal › Letter › peer-review
Press/Media
-
Weekly: OraSure Technologies (OSUR: $2.94) down 8% in 2 weeks; -24.5c [-7.7%]
3/23/26
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: OraSure Technologies (OSUR: $2.97) pulls back 7% on thin volume; -22c [-6.9%]
3/16/26
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: OraSure Technologies (OSUR: $3.19) up 16% in 2 weeks; +44c [16.0%]
3/9/26
1 item of Media coverage
Press/Media: Press / Media
-
Tech-Enabled Diagnostics Companies Having a Moment
3/5/26
1 item of Media coverage
Press/Media: Press / Media
-
OraSure Technologies strengthens 0.6% in past year
3/3/26
1 item of Media coverage
Press/Media: Press / Media